Sponsor Pipeline

Beijing Northland Biotech. Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
Active Trials by Phase
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07586865 Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction Acute Myocardial Infarction (AMI) Not Yet Recruiting
Not specified
NCT07023965 Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L) Peripheral Arterial Disease(PAD) Enrolling by Invitation
Get alerts when Beijing Northland Biotech. Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free